Filters

Anti-Human NOV

Anti-Human NOV size: 100ug 336

Price 336
Size 100ug
Gene NameNOV
Species ReactivityHuman (Homo sapiens)
Synonyms NOV
UniprotQ9UIW2
Description this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against
Storage and handling Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetNOV
Short nameAnti- NOV
Species Humans, Human
Alternative name sapiens NOV, antibody to-H
Identity 9099
Gene PLXNA1
Long gene name plexin A1
Synonyms gene PLXN1
Locus 3q21, 3
Discovery year 1998-08-13
GenBank acession X87832
Entrez gene record 5361
Pubmed identfication 8570614
RefSeq identity NM_032242
Classification Plexins
Havana BLAST/BLAT OTTHUMG00000044222

Subscribe to our Newsletter